Cellular Therapies & Biotherapies

Cellular therapies and biotherapies are growing areas of medicine that are transforming patient care. AABB works with the cellular therapies community to drive policies that ensure patient access, advance research, increase the supply and safety biological products, and expand coverage for these transformative therapies.

Policy Priorities

Advance a sustainable supply of cellular starting materials critical for innovative treatments.
Support the safety and well-being of donors providing cellular starting materials.
Support patient access to safe and effective biotherapies and cellular therapies.
Support modernizing regulatory frameworks that accelerate the development and reduce the costs of point-of-care biotherapies, such as cell and gene therapies.
Promote policies that reduce burdens on patients and caregivers by facilitating access to collections for biotherapies in hospitals, blood centers, community-based clinics and all safe settings of care.